2 recruiting, 1 not yet recruiting, 1 withdrawn. 1 Not applicable, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow HIV 1 Infection: new trials by email Literature Review of HIV 1 Infection trials Research Report on HIV 1 Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study on Retention in Care and on Clinical Chracteristics of HIV-infected Women Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIKWO). Bictegravir (BIC) plus Emtricitabine (FTC) plus Tenofovir Alafenamide (TAF) - HIV 1 Infection | Not yet recruiting | Ente Ospedaliero Ospedali Galliera | 100 | 2026-12-15 | 2026-10-09 | |
| REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE Bictegravir, emtricitabine, and tenofovir alafenamide - HIV -1 Infection, HIV (Human Immunodeficiency Virus) | Phase 4 | Recruiting | CAN Community Health | 200 | 2026-06-17 | 2026-09-03 |
| A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test TruPlex HIV/HepB/Syphilis Rapid Test - HIV 1 Infection, HIV 2 Infection | Not applicable | Recruiting | bioLytical Laboratories | 1000 | 2025-12-18 | 2026-10-02 |
| Dapivirine Gel Rectal Safety and PK Study Dapivirine gel (0.05%), Universal HEC placebo gel - HIV 1 Infection | Phase 1 | Withdrawn | International Partnership for Microbicides, Inc. | 2015-09-29 | 2017-02-08 |
Acquired Immunodeficiency Syndrome (2) · HIV Infections (1) · Hepatitis B (1)
Blood-Borne Infections (3) · Communicable Diseases (3) · Infections (3) · Virus Diseases (3) · Genital Diseases (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Lentivirus Infections (2) · RNA Virus Infections (2) · Retroviridae Infections (2) · Sexually Transmitted Diseases (2) · Sexually Transmitted Diseases, Viral (2) · Slow Virus Diseases (2) · Urogenital Diseases (2) · DNA Virus Infections (1)
Racivir (1) · bictegravir (1) · bictegravir, emtricitabine, tenofovir alafenamide, drug combination (1) · imidazole mustard (1)
CAN Community Health (1) · Ente Ospedaliero Ospedali Galliera (1) · International Partnership for Microbicides, Inc. (1) · bioLytical Laboratories (1)
United States (2) · Italy (1) · South Africa (1)
Hector Bolivar, MD (1) · Jessica Altamirano, MD (1)